Intracranial hemorrhage (ICH) is the most feared complication of oral anticoagulant therapy because of the high rates of mortality and disability. 
Some bleeding risk scores have been derived and validated in patients with NVAF treated with oral anticoagulants: HAS-BLED, 9 HEMORR 2 HAGES, 10 ATRIA, 11 and ORBIT. 12 These scores show only modest power to predict bleeding events and do not outperform ischemic risk scores, such as CHA 2 DS 2 -VASc. [13] [14] [15] It is still unclear whether robust risk factors associated with ICH exist in patients treated with VKAs and if bleeding risk scores commonly used are able to reliably predict ICH.
To evaluate whether there are risk factors or risk scores associated to ICH in patients treated with VKAs, we set up a casecontrol study using data retrieved from the electronic records of the Thrombosis Center at Padua University Hospital.
| ME THODS

| Study setting
This is a single-center case-control study designed to assess the relationship between recorded risk factors and ICH. We matched cases and controls in a 1:4 ratio to maximize the power of the study.
Enrolled patients were followed at the Thrombosis Center of Padua University Hospital, one of the largest thrombosis centers in Italy.
Patient-relevant data were collected using two hospital-based informatic systems:
• PARMA 5.7 (Systelab Technologies, Werfen, Lliçà d'Amunt, Spain), a software specifically designed to manage anticoagulation therapy with VKAs, to obtain all patient and VKA therapy-related data as well as events.
• Galileo's eHealth application platform (NoemaLife, Bologna, Italy) was used to cross-check for relevant events as it contains reports of emergency room and/or hospital admissions, specialist medical records and blood tests. 
| Cases and controls selection
We used PARMA 5.7 software, to identify patients who experienced ICH during treatment with VKAs, described by the com- Written informed consent to the processing of personal information was obtained from each patient at the time of first access at the Thrombosis Center. Recording of medical information, without identifiers, by an investigator who does not have patient care responsibilities was exempt from institutional review board evaluation.
| Statistical analysis
Qualitative data were reported as counts and percentages.
Quantitative variables were recorded as median, interquartile range (IQR) and mean ± standard deviation (SD) according to the data distribution. The normal distribution of quantitative variables was verified using Kolmogorov-Smirnov's test. Continuous variables were compared using the Student's t test. Categorical and continuous variables not normally distributed were compared using MannWhitney's test. We considered the values of bleeding risk scores as categorical variables. The risk of developing ICH was tested using linear logistic regression.
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Receiver operator characteristic (ROC) curves were used to illustrate the performance of bleeding scores in predicting ICH. The C-statistic, a measure of the area under the curve, quantified the predictive value of each score and tested the hypothesis that these scores performed significantly better than chance. We used the software IBM SPSS Statistic v.24 (International Business Machine Corporation, New York, United States of America) to perform statistical analysis.
The data that support the findings of this study is available from the corresponding author upon reasonable request. 
| RE SULTS
| Case-control study
Demographic, laboratory, and clinical characteristics of cases and controls are listed in Table 2 . There was no difference between cases and controls in the assessed variables. Moreover, on linear logistic regression model, none of the risk factors predicted ICH. Using a cluster risk factor composed of anemia and vascular disease, there was a trend toward possible association (OR 1.9; 95% CI 0.9-4.1,
No statistically significant differences were found between cases and controls when comparing ischemic risk score CHA 2 DS 2 -VASc and bleeding risk scores HAS-BLED, ATRIA, and ORBIT (Table 3) .
ROC curves to evaluate the predictive values of bleeding risk scores are shown in Figure 1 . To increase the prediction power, the chosen cut-off points which differentiate between the low bleeding risk category and the intermediate to high bleeding risk category were >3 for HAS-BLED and ATRIA and >2 for ORBIT score.
Areas under the curves of all bleeding risk scores were similar, with C-statistic less than 0.6 for all of them (C-statistics for HAS-BLED, ATRIA, and ORBIT were 0.55, 0.53 and 0.54, respectively).
Therefore, these three scores have no statistically significant predictive ability for ICH (Table 4) . 
| D ISCUSS I ON
In this retrospective study, we found 51 ICHs in patients with NVAF treated with warfarin. Patients suffering from this complication were very elderly (≥80 years old in 72.5% of cases), confirming reports that indicate this population as being at a potentially higher risk of ICH. 6, 20, 21 Geriatric patients represent the lion's share of patients with multiple comorbidities and comedications.
There is evidence of progressive increase in overall burden, incidence, prevalence, and atrial fibrillation-associated mortality.
22
Most patients with atrial fibrillation deserve oral anticoagulant treatment. 19 Warfarin is still widely used and among drugs most commonly causing access to emergency department, 23 mainly for bleeding complications. ICH is uncommon 2-5 but the case fatality rate may be up to 50%. 3, 6 We confirm previous findings, 24 the follow-up period (2 years, ranging from 1 to 4 years). ICH is a potentially fatal complication. 5, 6, 20, 21, 27 In our cohort, more than a quarter of cases were fatal, mainly when the event was spontaneous, and the site was intraparenchymal. Post-traumatic ICHs are also serious events and patient's outcome might be driven by VKA treatment, but also by the severity of trauma itself. ICH was difficult to predict by commonly used bleeding risk scores even in NOAC trials. 15 However, because the use of NOACs markedly reduces ICH incidence, 39-43 they should be used as firstline treatment as recommended by current guidelines. 
| Limitations of the study
Despite the robust analysis, limitations of the study include its retrospective design and data collection from routine electronic health records. In our analysis, we did not include the HEMORR 2 HAGES bleeding risk score, because of unfeasibility of obtaining data on genetic risk factors and fall risk 10 of our cohort. However, this score is not commonly used in clinical practice, owing to the complexity that is required for its calculation. The term "ICH" comprises different clinical entities such as intraparenchymal, subarachnoid, and subdural bleedings, either spontaneous or post-traumatic. To reduce bias form this broad definition, we examined the subgroup of spontaneous intraparenchymal bleeding and found no differences in the predictive value of bleeding risk scores as compared to the main analysis. However, these results need confirmation from longitudinal studies.
On the other hand, our study has important implications: clinicians should define the risk/benefit ratio of anticoagulation therapy, based on an individual basis, rather than on current bleeding risk scores.
| CON CLUS IONS
Results from this case-control study show that ICH is frequent among very elderly patients treated with VKAs. ICH is not associated with any known risk factor and cannot be predicted by commonly used bleeding risk scores.
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